Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Publication | Closed Access

DOI

Citations

References

2017

Year

Gillian Duchesne, Henry H. Woo, Madeleine King, Steven J. Bowe, Martin R. Stockler, Alice Ames, Catherine D’Este, Mark Frydenberg, Andrew Loblaw, Shawn Malone,

The Lancet Oncology

Quality Of LifeAndrogen-deprivation TherapyUrologyHealth SciencesHealth-related QualityMedicineCancer ManagementOutcomes ResearchPatient-reported OutcomeProstatic DiseaseOncologyRadiation OncologyTrog 03.06